Cameron Trenor

Cameron Trenor joined Cellarity in January 2023 as the Head of Translational Medicine. He brings his background as a practicing clinician, clinical and bench researcher and with clinical development expertise from preclinical concept through launch to Cellarity.  As the first clinician at Cellarity, Cameron is representing the patient’s perspective in programs and building the team for translation to clinic in preparation for entry of our first compounds into clinic.

Before joining Cellarity, Cameron was an Executive Director, Clinical Development at Forma Therapeutics/Novo Nordisk in Watertown, MA. In this role, he supervised the phase 2/3 etavopivat study in sickle cell disease (Hibiscus), opened and supervised multiple ph2 clinical trials and expanded the clinical development team. The clinical investigation of etavopivat is truly global, with sites in US, EU, Middle East and Africa and leadership of this program involved oversight of multiple CROs. Cameron’s role also included responsibilities to the Life Cycle team, frequent presentations to the Executive Leadership Team and BoD and engagements with investors and partners, including through the NovoNordisk acquisition in October 2022.

Prior to joining Forma, Cameron worked as a Senior Translational Medicine Expert 1 at Novartis Institutes of BioMedical Research in Cambridge, MA.  He consulted on preclinical hematology and rare disease programs and led cross-functional teams from Development Candidate through IND/CTA to proof-of concept.  These Investigational Products ranged from small molecules, biologics, antibody-drug conjugates and genetically-engineered autologous cellular therapies.

Cameron holds an MD from the University of Tennessee and an MMSc from Harvard Medical School. He has led NIH- and philanthropically-funded bench research and has led investigator-initiated and industry-sponsored clinical research while he was full-time faculty at Boston Children’s Hospital, Dana-Farber Cancer Institute and Harvard Medical School.  This work has led to over 70 publications.  Cameron continues to practice as an active pediatric hematologist/oncologist in a multidisciplinary specialty clinic at Boston Children’s Hospital.